Developing a computer algorithm to identify epilepsy cases in managed care organizations.

The goal of this study was to develop an algorithm for detecting epilepsy cases in managed care organizations (MCOs). A data set of potential epilepsy cases was constructed from an MCO's administrative data system for all health plan members continuously enrolled in the MCO for at least 1 year within the study period of July 1, 1996 through June 30, 1998. Epilepsy status was determined using medical record review for a sample of 617 cases. The best algorithm for detecting epilepsy cases was developed by examining combinations of diagnosis, diagnostic procedures, and medication use. The best algorithm derived in the exploratory phase was then applied to a new set of data from the same MCO covering the period of July 1, 1998 through June 30, 2000. A stratified sample based on ethnicity and age was drawn from the preliminary algorithm-identified epilepsy cases and non-cases. Medical record review was completed for 644 cases to determine the accuracy of the algorithm. Data from both phases were combined to permit refinement of logistic regression models and to provide more stable estimates of the parameters. The best model used diagnoses and antiepileptic drugs as predictors and had a positive predictive value of 84% (sensitivity 82%, specificity 94%). The best model correctly classified 90% of the cases. A stable algorithm that can be used to identify epilepsy patients within MCOs was developed. Implications for use of the algorithm in other health care settings are discussed.

[1]  Olga V. Demler,et al.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.

[2]  L. Trost.  Epilepsy in a managed care organization. , 2000, Neurology.

[3]  W. Hauser.  Recent developments in the epidemiology of epilepsy , 1995, Acta neurologica Scandinavica. Supplementum.

[4]  Josemir W Sander,et al.  MEDICAL SCIENCE National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population , 1990, The Lancet.

[5]  P. Jallon.  Epilepsy and epileptic disorders, an epidemiological marker? Contribution of descriptive epidemiology. , 2002, Epileptic disorders : international epilepsy journal with videotape.

[6]  J. Annegers,et al.  The Incidence of Epilepsy and Unprovoked Seizures in Multiethnic, Urban Health Maintenance Organizations , 1999, Epilepsia.

[7]  Louis Sherwood,et al.  From Outcomes Research to Disease Management: A Guide for the Perplexed , 1996, Annals of Internal Medicine.

[8]  Josemir W Sander,et al.  CPD — Education and self-assessment The epidemiology of epilepsy: the size of the problem , 2001, Seizure.

[9]  J. Knottnerus,et al.  Systematic Review and Meta‐analysis of Incidence Studies of Epilepsy and Unprovoked Seizures , 2002, Epilepsia.

[10]  M. Gunter,et al.  Impact of a seizure disorder disease management program on patient-reported quality of life. , 2004, Disease management : DM.

[11]  S. Shorvon,et al.  Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2 052 922 and age-specific fertility rates of women with epilepsy , 1998, The Lancet.

[12]  S. Shorvon.  The Epidemiology and Treatment of Chronic and Refractory Epilepsy , 1996, Epilepsia.